Centaurus Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-706
Closed -$4.82K 647
2019
Q1
$4.82K Buy
706
+45
+7% +$6.52K 0.03% 354
2018
Q4
$5 Buy
661
+656
+13,120% +$108K 0.04% 296
2018
Q3
$998 Sell
5
-5,603
-100% -$1.03M 0.18% 139
2018
Q2
$935K Buy
5,608
+408
+8% +$65.5K 0.13% 179
2018
Q1
$875K Buy
+5,200
New +$872K 0.21% 125

Other funds holding AGN

Centaurus Financial's AGN Position: Q2 2019 in Review

Centaurus Financial sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 706 shares — an estimated $4.82K sold.

Centaurus Financial first reported a position in AGN in Q1 2018 and held it in 5 quarters. The position peaked at $935K in Q2 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Centaurus Financial reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Centaurus Financial sold 706 Allergan plc shares in Q2 2019, an estimated $4.82K.
  • Centaurus Financial first reported a position in Allergan plc in Q1 2018 and held it in 5 quarters.
  • Centaurus Financial's Allergan plc position peaked at $935K in Q2 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Centaurus Financial's 13F filing for Q2 2019, filed 15 Aug 2019.